Compare Novartis AG (NVS) vs Orion Office REIT Inc (ONL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Orion Office REIT Inc — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while Orion Office REIT Inc trades at $2.72 (market cap $158.01M). The key difference: Novartis AG is far larger — about 1869.3× Orion Office REIT Inc's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| NVS | ONL | |
|---|---|---|
Market Cap | $295.37B | $158.01M |
Sector | Health | Real Estate |
52-Week High | $168.62 | $3.04 |
52-Week Low | $119.31 | $1.93 |
Enterprise Value | $336.69B | $574.95M |
Dividend Yield | 3.07% | 2.89% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Orion Office REIT Inc
Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →
